Andrew Spaventa - Aug 12, 2024 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Aug 12, 2024
Transactions value $
-$4,849
Form type
4
Date filed
8/14/2024, 05:11 PM
Previous filing
Jun 18, 2024
Next filing
Sep 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +1.91K +586.46% 2.23K Aug 12, 2024 Direct F1, F2
transaction OMIC Common Stock Tax liability -$4.85K -681 -30.52% $7.12 1.55K Aug 12, 2024 Direct F3
transaction OMIC Common Stock Gift $0 -1.23K -79.03% $0.00 325 Aug 12, 2024 Direct F4
transaction OMIC Common Stock Gift $0 +1.23K +0.88% $0.00 140K Aug 12, 2024 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F2, F4
holding OMIC Common Stock 85 Aug 12, 2024 By Axon Holdings, LLC F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise $0 -1.91K -6.67% $0.00 26.7K Aug 12, 2024 Common Stock 1.91K Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 On June 26, 2024, the Issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
F3 Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the settlement of RSUs.
F4 Immediately upon settlement of the vested RSUs, and following the withholding described above, the Reporting Person transferred the shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F5 The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F6 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F7 The RSUs vest in 16 equal quarterly installments over four years measured from February 12, 2024.